I think the bigger story is how BIIB got caught with its pants down in MS, it's major market. How were they not the leader in developing oral treatments? I don't think BG-12, their lead oral, is considered that impressive either.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.